Five Advances in the Last 50 Years: Liver Malignancies

Alex B. Blair; Timothy M. Pawlik

doi:10.1002/wjs.70327

journal article Open Access Apr 11, 2026

Five Advances in the Last 50 Years: Liver Malignancies

Alex B. Blair Timothy M. Pawlik

Molecular Medicine · Springer Science and Business Media LLC

View at Publisher Save 10.1002/wjs.70327

Topics

No keywords indexed for this article. Browse by subject →

References

56

[1]

Langenbuch D. "A Case of Resection of the Left Lobe of the Liver [Ein Fall von Resektion eines linksseitigen Schnurlappens der Leber]" Berliner Klinische Wochenschrift. (1888)

[2]

Cantlie J. "On a New Arrangement of the Right and Left Lobes of the Liver" Proceedings—Anatomical Society of Great Britain and Ireland (1897)

[3]

10.1097/00000658‐190810000‐00005

[4]

Couinaud C. "Segmental and Lobar Left Hepatectomies; Studies on Anatomical Conditions" Journal de Chirurgie (1952)

[5]

10.1002/1097‐0142(19800515)45:10<2663::aid‐cncr2820451030>3.0.co;2‐g

[6]

10.1016/s0011‐3840(72)80002‐9

[7]

10.1016/j.amjsurg.2003.12.001

[8]

10.1016/s1072‐7515(98)00240‐3

[9]

10.1016/s1091‐255x(00)80052‐9

[10]

10.3748/wjg.v12.i6.935

[11]

10.1111/j.1463‐1318.2009.01803.x

[12]

10.1200/jco.1997.15.2.808

[13]

Phase III Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Compared With Infusional Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) As First-Line Treatment for Metastatic Colorectal Cancer: The Gruppo Oncologico Nord Ovest

Alfredo Falcone, Sergio Ricci, Isa Brunetti et al.

Journal of Clinical Oncology 10.1200/jco.2006.09.0928

[14]

10.1158/1078‐0432.ccr‐21‐0557

[15]

Sorafenib in Advanced Hepatocellular Carcinoma

Josep M. Llovet, Sergio Ricci, Vincenzo Mazzaferro et al.

New England Journal of Medicine 10.1056/nejmoa0708857

[16]

10.1159/000539897

[17]

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

Richard S. Finn, Shukui Qin, Masafumi Ikeda et al.

New England Journal of Medicine 10.1056/nejmoa1915745

[18]

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

B. Sangro, S.L. Chan, R.K. Kelley et al.

Annals of Oncology 10.1016/j.annonc.2024.02.005

[19]

Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma

Ghassan K. Abou-Alfa, George Lau, Masatoshi Kudo et al.

NEJM Evidence 10.1056/evidoa2100070

[20]

10.1016/j.jhep.2025.05.003

[21]

10.1016/s2468‐1253(24)00095‐5

[22]

10.1016/s0140‐6736(23)00727‐4

[23]

10.1002/jso.23671

[24]

10.1007/bf01655244

[25]

Makuuchi M. "Preoperative Portal Embolization to Increase Safety of Major Hepatectomy for Hilar Bile Duct Carcinoma: A Preliminary Report" Surgery (1990)

[26]

10.1016/j.lanepe.2025.101284

[27]

10.1245/s10434‐019‐08192‐z

[28]

10.1016/j.suronc.2020.01.010

[29]

Breedis C. "The Blood Supply of Neoplasms in the Liver" American Journal Of Pathology (1954)

[30]

Konno T. "Arterial administration of SMANCS and Other Antitumor Agents Dissolved in Lipiodol for Various Malignant Solid Tumors" Nihon Geka Gakkai Zasshi (1984)

[31]

10.1016/j.ctrv.2021.102258

[32]

10.1097/meg.0b013e3283502241

[33]

10.1007/s00270‐006‐0062‐3

[34]

10.1016/j.jamcollsurg.2019.12.026

[35]

10.5582/bst.2015.01089

[36]

Transarterial Radioembolization with Yttrium-90 and SIRT Versus Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis

João Pedro Toledo Lima de Alcântara, George Willian Xavier da Rosa Götz

Academic Radiology 10.1016/j.acra.2025.06.008

[37]

10.1016/j.jvir.2022.02.016

[38]

Ensminger W. D. "Hepatic Arterial Infusion Chemotherapy for Metastatic Liver Cancers" Comprehensive Therapy (1984)

[39]

10.1016/j.jamcollsurg.2005.03.019

[40]

10.1093/jnci/djae202

[41]

10.1200/jco.2016.71.8346

[42]

10.1093/bjs/znae089

[43]

Franssen S. "Hepatic Arterial Infusion Pump Chemotherapy in Patients With Unresectable Intrahepatic Cholangiocarcinoma‐PUMP‐2 Trial" Journal of Clinical Oncology (2025)

[44]

10.21037/jgo‐24‐71

[45]

10.1245/s10434‐019‐07973‐w

[46]

10.1097/00007611‐197704000‐00001

[47]

10.1097/00000658‐198510000‐00001

[48]

10.1007/bf01659064

[49]

Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis

Vincenzo Mazzaferro, Enrico Regalia, Roberto Doci et al.

New England Journal of Medicine 10.1056/nejm199603143341104

[50]

10.1200/jco.2003.11.137

Showing 50 of 56 references

Metrics

0

Citations

56

References

Details

Published: Apr 11, 2026
License: View

Authors

A

Alex B. Blair

Department of Surgery The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center Columbus Ohio USA

T

Timothy M. Pawlik

Department of Surgery The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center Columbus Ohio USA

Cite This Article

Alex B. Blair, Timothy M. Pawlik (2026). Five Advances in the Last 50 Years: Liver Malignancies. Molecular Medicine. https://doi.org/10.1002/wjs.70327

Five Advances in the Last 50 Years: Liver Malignancies

You May Also Like